ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 55 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $341,000 | -3.7% | 262,358 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $354,000 | -6.8% | 262,358 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $380,000 | -43.4% | 262,358 | -12.0% | 0.00% | -50.0% |
| Q4 2017 | $671,000 | -33.8% | 298,303 | +0.0% | 0.00% | -50.0% |
| Q3 2017 | $1,014,000 | -4.2% | 298,248 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,059,000 | -24.6% | 298,248 | -27.8% | 0.00% | -33.3% |
| Q1 2017 | $1,405,000 | -26.1% | 413,278 | 0.0% | 0.01% | -25.0% |
| Q4 2016 | $1,901,000 | +8.5% | 413,278 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $1,752,000 | +76.6% | 413,278 | 0.0% | 0.01% | +60.0% |
| Q2 2016 | $992,000 | -48.9% | 413,278 | 0.0% | 0.01% | -44.4% |
| Q1 2016 | $1,942,000 | +86.2% | 413,278 | +55.7% | 0.01% | +80.0% |
| Q4 2015 | $1,043,000 | – | 265,348 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,699,848 | $17,019,000 | 2.88% |
| Northeast Financial Consultants Inc | 732,265 | $3,368,000 | 1.50% |
| Family Management Corp | 12,008 | $55,000 | 0.04% |
| Acrospire Investment Management LLC | 6,101 | $28,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 148,054 | $681,000 | 0.01% |
| THRIVENT FINANCIAL FOR LUTHERANS | 413,278 | $1,901,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 48,790 | $224,000 | 0.01% |
| Parallel Advisors, LLC | 3,538 | $16,000 | 0.00% |
| Squarepoint Ops LLC | 15,690 | $72,000 | 0.00% |
| WILLIAMS JONES & ASSOCIATES LLC | 15,100 | $69,000 | 0.00% |